GTSE1 and cancer: Using data from TCGA, ArrayExpress, and GEO databases, GTSE1 was found to be significantly overexpressed in various tumors, correlating with clinical features and survival rates, suggesting its potential as a biomarker for pan‐cancer prognosis and a target for immunotherapy.